Comparative Pharmacology
Head-to-head clinical analysis: FREAMINE HBC 6 9 versus FREAMINE III 8 5.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FREAMINE HBC 6 9 versus FREAMINE III 8 5.
FREAMINE HBC 6.9% vs FREAMINE III 8.5%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FREAMINE HBC 6.9% is a branched-chain amino acid (BCAA) solution that provides essential and non-essential amino acids. It promotes protein synthesis and serves as a substrate for gluconeogenesis. BCAAs may compete with tryptophan and aromatic amino acids for entry into the brain, potentially reducing hepatic encephalopathy.
FREAMINE III 8.5% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis, nitrogen balance maintenance, and tissue repair. It acts as a substrate for protein anabolism in patients unable to tolerate adequate oral or enteral intake.
Intravenous infusion, 1.0 to 2.0 g amino acids/kg/day (14.5 to 29.0 mL/kg/day of FREAMINE HBC 6.9%). Typically 0.5-1.0 L per day in adults, titrated to metabolic needs.
Intravenous infusion; typical adult dose is 0.8-1.5 g amino acids/kg/day (equivalent to 9.4-17.6 mL/kg/day of Freamine III 8.5%). Initiate at lower end and titrate to metabolic needs. Administer via central or peripheral line with dextrose and electrolytes as part of parenteral nutrition.
None Documented
None Documented
Not applicable as a mixture; individual amino acids have half-lives ranging from minutes to hours. For clinical purposes, infusion rate and metabolic clearance are monitored rather than half-life.
Terminal elimination half-life of infused amino acids is approximately 15-30 minutes for most, but albumin synthesis half-life is 20-22 days; clinical context: continuous infusion needed for nitrogen balance.
Amino acids are primarily eliminated via metabolism; <2% excreted unchanged in urine. Excess nitrogen is converted to urea and excreted renally as urea. Biliary/fecal elimination is negligible.
Renal: 90-95% of infused amino acids are reabsorbed; excess nitrogen excreted as urea (80-90% of nitrogen load) and ammonia (<10%). Biliary/fecal: negligible (<5%).
Category C
Category C
Parenteral nutrition amino acid
Parenteral nutrition amino acid